Literature DB >> 8035827

Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis.

B Lutterbach1, S R Hann.   

Abstract

The N-terminal domain of the c-Myc protein has been reported to be critical for both the transactivation and biological functions of the c-Myc proteins. Through detailed phosphopeptide mapping analyses, we demonstrate that there is a cluster of four regulated and complex phosphorylation events on the N-terminal domain of Myc proteins, including Thr-58, Ser-62, and Ser-71. An apparent enhancement of Ser-62 phosphorylation occurs on v-Myc proteins having a mutation at Thr-58 which has previously been correlated with increased transforming ability. In contrast, phosphorylation of Thr-58 in cells is dependent on a prior phosphorylation of Ser-62. Hierarchical phosphorylation of c-Myc is also observed in vitro with a specific glycogen synthase kinase 3 alpha, unlike the promiscuous phosphorylation observed with other glycogen synthase kinase 3 alpha and 3 beta preparations. Although both p42 mitogen-activated protein kinase and cdc2 kinase specifically phosphorylate Ser-62 in vitro and cellular phosphorylation of Thr-58/Ser-62 is stimulated by mitogens, other in vivo experiments do not support a role for these kinases in the phosphorylation of Myc proteins. Unexpectedly, both the Thr-58 and Ser-62 phosphorylation events, but not other N-terminal phosphorylation events, can occur in the cytoplasm, suggesting that translocation of the c-Myc proteins to the nucleus is not required for phosphorylation at these sites. In addition, there appears to be an unusual block to the phosphorylation of Ser-62 during mitosis. Finally, although the enhanced transforming properties of Myc proteins correlates with the loss of phosphorylation at Thr-58 and an enhancement of Ser-62 phosphorylation, these phosphorylation events do not alter the ability of c-Myc to transactivate through the CACGTG Myc/Max binding site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035827      PMCID: PMC359071          DOI: 10.1128/mcb.14.8.5510-5522.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  74 in total

Review 1.  Control of c-myc regulation in normal and neoplastic cells.

Authors:  C A Spencer; M Groudine
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

2.  ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF.

Authors:  T G Boulton; S H Nye; D J Robbins; N Y Ip; E Radziejewska; S D Morgenbesser; R A DePinho; N Panayotatos; M H Cobb; G D Yancopoulos
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

3.  Mutational analysis of the carboxy-terminal casein kinase II phosphorylation site in human c-myc.

Authors:  A J Street; E Blackwood; B Lüscher; R N Eisenman
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

Review 4.  Multisite and hierarchal protein phosphorylation.

Authors:  P J Roach
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

5.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity.

Authors:  W J Boyle; T Smeal; L H Defize; P Angel; J R Woodgett; M Karin; T Hunter
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

6.  Identification of the human c-myc protein nuclear translocation signal.

Authors:  C V Dang; W M Lee
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

7.  The transforming activity of the chicken c-myc gene can be potentiated by mutations.

Authors:  L Frykberg; T Graf; B Vennström
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

8.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

9.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

Authors:  E M Blackwood; R N Eisenman
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

10.  Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase.

Authors:  E Alvarez; I C Northwood; F A Gonzalez; D A Latour; A Seth; C Abate; T Curran; R J Davis
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

View more
  84 in total

1.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.

Authors:  D W Chang; G F Claassen; S R Hann; M D Cole
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

3.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

Authors:  R Sears; F Nuckolls; E Haura; Y Taya; K Tamai; J R Nevins
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

Review 4.  Cell cycle and apoptosis.

Authors:  Katrien Vermeulen; Zwi N Berneman; Dirk R Van Bockstaele
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

5.  Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

Authors:  Masayoshi Yada; Shigetsugu Hatakeyama; Takumi Kamura; Masaaki Nishiyama; Ryosuke Tsunematsu; Hiroyuki Imaki; Noriko Ishida; Fumihiko Okumura; Keiko Nakayama; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

6.  DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells.

Authors:  Naoe Taira; Rei Mimoto; Morito Kurata; Tomoko Yamaguchi; Masanobu Kitagawa; Yoshio Miki; Kiyotsugu Yoshida
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

7.  Deubiquitinating c-Myc: USP36 steps up in the nucleolus.

Authors:  Xiao-Xin Sun; Rosalie C Sears; Mu-Shui Dai
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 Inhibitors.

Authors:  Zhaojun Qiu; Pengyan Fa; Tao Liu; Chandra B Prasad; Shanhuai Ma; Zhipeng Hong; Ernest R Chan; Hongbing Wang; Zaibo Li; Kai He; Qi-En Wang; Terence M Williams; Chunhong Yan; Steven T Sizemore; Goutham Narla; Junran Zhang
Journal:  Cancer Res       Date:  2020-06-10       Impact factor: 12.701

9.  The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity.

Authors:  Julienne R Escamilla-Powers; Colin J Daniel; Amy Farrell; Karyn Taylor; Xiaoli Zhang; Sarah Byers; Rosalie Sears
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

10.  AtSKtheta, a plant homologue of SGG/GSK-3 marks developing tissues in Arabidopsis thaliana.

Authors:  R Tavares; J Vidal; A van Lammeren; M Kreis
Journal:  Plant Mol Biol       Date:  2002-09       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.